Annual Long Term Debt
$8.79 M
-$19.05 M-68.43%
31 December 2023
Summary:
Cartesian Therapeutics annual long term debt is currently $8.79 million, with the most recent change of -$19.05 million (-68.43%) on 31 December 2023. During the last 3 years, it has fallen by -$25.65 million (-74.48%). RNAC annual long term debt is now -74.48% below its all-time high of $34.44 million, reached on 01 December 2020.RNAC Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$11.88 M
-$463.00 K-3.75%
01 September 2024
Summary:
Cartesian Therapeutics quarterly long term debt is currently $11.88 million, with the most recent change of -$463.00 thousand (-3.75%) on 01 September 2024. Over the past year, it has increased by +$3.19 million (+36.66%). RNAC quarterly long term debt is now -65.54% below its all-time high of $34.48 million, reached on 01 September 2020.RNAC Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.4% | +36.7% |
| 3 y3 years | -74.5% | -60.6% |
| 5 y5 years | - | - |
RNAC Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | at low | -64.4% | +44.4% |
| 5 y | 5 years | -74.5% | -65.5% | ||
| alltime | all time | -74.5% | -65.5% |
Cartesian Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.88 M(-3.8%) |
| June 2024 | - | $12.34 M(+50.0%) |
| Mar 2024 | - | $8.23 M(-6.4%) |
| Dec 2023 | $8.79 M(-68.4%) | $8.79 M(+1.1%) |
| Sept 2023 | - | $8.69 M(-62.1%) |
| June 2023 | - | $22.95 M(-11.2%) |
| Mar 2023 | - | $25.84 M(-7.2%) |
| Dec 2022 | $27.84 M(-1.5%) | - |
| Dec 2022 | - | $27.84 M(-9.4%) |
| Sept 2022 | - | $30.72 M(+0.2%) |
| June 2022 | - | $30.65 M(-8.1%) |
| Mar 2022 | - | $33.36 M(+18.0%) |
| Dec 2021 | $28.27 M(-17.9%) | $28.27 M(-6.3%) |
| Sept 2021 | - | $30.18 M(-5.9%) |
| June 2021 | - | $32.07 M(-5.5%) |
| Mar 2021 | - | $33.95 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $34.44 M(>+9900.0%) | $34.44 M(-0.1%) |
| Sept 2020 | - | $34.48 M(+108.1%) |
| June 2020 | - | $16.57 M(+58.7%) |
| Mar 2020 | - | $10.44 M(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2018 | - | $21.21 M(+0.4%) |
| Mar 2018 | - | $21.13 M(+0.4%) |
| Dec 2017 | $21.04 M(+163.8%) | $21.04 M(+0.4%) |
| Sept 2017 | - | $20.95 M(+265.6%) |
| June 2017 | - | $5.73 M(-16.5%) |
| Mar 2017 | - | $6.87 M(-13.9%) |
| Dec 2016 | $7.98 M(-32.7%) | $7.98 M(-12.0%) |
| Sept 2016 | - | $9.06 M(-10.5%) |
| June 2016 | - | $10.13 M(-9.3%) |
| Mar 2016 | - | $11.17 M(-5.8%) |
| Dec 2015 | $11.86 M(+145.8%) | $11.86 M |
| Dec 2014 | $4.82 M | - |
FAQ
- What is Cartesian Therapeutics annual long term debt?
- What is the all time high annual long term debt for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual long term debt year-on-year change?
- What is Cartesian Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly long term debt year-on-year change?
What is Cartesian Therapeutics annual long term debt?
The current annual long term debt of RNAC is $8.79 M
What is the all time high annual long term debt for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual long term debt is $34.44 M
What is Cartesian Therapeutics annual long term debt year-on-year change?
Over the past year, RNAC annual long term debt has changed by -$19.05 M (-68.43%)
What is Cartesian Therapeutics quarterly long term debt?
The current quarterly long term debt of RNAC is $11.88 M
What is the all time high quarterly long term debt for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly long term debt is $34.48 M
What is Cartesian Therapeutics quarterly long term debt year-on-year change?
Over the past year, RNAC quarterly long term debt has changed by +$3.19 M (+36.66%)